+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Septal Occluder"

Congenital Heart Defect Devices: Focus on the U.S. Market - Product Thumbnail Image

Congenital Heart Defect Devices: Focus on the U.S. Market

  • Report
  • February 2020
  • 25 Pages
  • United States
From
From
Global Atrial Septal Occluder Devices Market - Product Thumbnail Image

Global Atrial Septal Occluder Devices Market

  • Report
  • June 2021
  • 10 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Septal Occluder market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat certain types of congenital heart defects, such as atrial septal defects (ASD). These devices are designed to close the hole in the wall between the two upper chambers of the heart, allowing the patient to lead a normal life. The Septal Occluder market is composed of a variety of products, including occluder devices, delivery systems, and accessories. The Septal Occluder market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, and W.L. Gore & Associates. Other companies in the market include St. Jude Medical, Inc., CryoLife, Inc., and Occlutech International AB. Show Less Read more